The FDA has approved the first generic version of Alza Corp.The FDA has approved the first generic version of Alza Corp.'s Duragesic Patch (fentanyl transdermal system) The approval, granted to Mylan Technologies Inc. of St Albans, Vt is look forward toed to give patients a lower-cost alternative of this pain management system The patch is applied to the skin and delivers fentanyl, an opioid pain medication used to treat clan with severe chronic pain that cannot be managed with alternative analgesics. The mix with drugs is slowly absorbed into the material substance providing pain relief for up to three days. The original fentanyl transdermal combination of parts to form a whole was approved in 1990. It is approved for managing chronic pain in populace who require continuous opioid analgesia for pain that can't be managed by way of acetaminophen-opioid combinations, non-steroidal analgesics, or as-needed dosing with short-acting opioids. Fentanyl is a Schedule II controll substance in a less degree than the Controlled Substances Act, which is the highest on a level of control for drugs with a recognized medical use. COPYRIGHT 2005 U conduct Printing Office |
| Home |
